June 7, 2017 / 4:12 PM / 2 months ago

BRIEF-STADA Arzneimittel: Bain Capital and Cinven lower minimum acceptance threshold

1 Min Read

June 7 (Reuters) - STADA ARZNEIMITTEL AG:

* BAIN CAPITAL AND CINVEN LOWER THE MINIMUM ACCEPTANCE THRESHOLD FOR THE TAKEOVER OFFER TO STADA'S SHAREHOLDERS FROM 75 PERCENT TO 67,5 PERCENT - ACCEPTANCE PERIOD EXTENDED UNTIL JUNE 22, 2017

* ‍EXECUTIVE BOARD AND SUPERVISORY BOARD WILL CONTINUE TO RECOMMEND TO SHAREHOLDERS OF STADA ARZNEIMITTEL AG TO ACCEPT OFFER​

* ‍EXECUTIVE BOARD AND SUPERVISORY BOARD ALSO THINK THAT TOTAL COMPENSATION OF EURO 66.00 PER STADA SHARE CONTINUES TO ADEQUATELY REFLECT ENTERPRISE VALUE AND REPRESENTS FINANCIALLY MOST ATTRACTIVE OFFER​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below